Companies
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Saved Searches
Following
Inbox
My Watchlists
About Us
Glossary

Create Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
0/300
Notifications Off
Public content (accessible by all Finder users)

Add to List

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Create Free Account
    Lock Icon
    Lock Icon
    8 Characters, Uppercase letter (A-Z),
    Lowercase letter (a-z), Digit (0-9)
    Lock Icon
    Passwords do not match
    Already have an account? Sign In
    Or continue with

    Verify your email

    We’ve sent a verification link to [email protected]
    Sign in
    Lock Icon
    Lock Icon
    Reset password
    Don't have an account? Create Account
    Or continue with

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    snackbar-icon
    title
    message
    Search Startups

    Stage Acquired, Tagged as ('cancer') Startups

    Processing your search... This may take a moment
    22 Startups 0 In the News 3 Recently Updated
    • Total Funding
      $1.27B
      Raised
      54
      Events
    • Private Funding
      $430.75M
      Raised
      19
      Rounds
    • Public Offerings
      $390M
      Raised
      15
      Offerings
    • M&A
      $450M
      Raised
      20
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags
    CANNDOC Pharma logo

    CANNDOC Pharma

    Acquired
    Pharma-grade Cannabis Products
    2008 B2B, B2B2C, B2C, B2G 1-10 Acquired Undisclosed
    cancer
    therapeutics
    parkinson
    epilepsy
    genetics
    pain-relief
    oncology
    inflammatory-diseases
    cannabis
    medical-cannabis
    oral-drugs
    pharmaceuticals
    ImmPACT Bio logo

    ImmPACT Bio

    Acquired
    CAR-T Cell Therapies for Treating Cancer
    2017 B2B 51-200 Acquired $137M
    biotechnology
    biopharmaceutical
    life-sciences
    genetic-engineering
    medical-technologies
    cancer-therapy
    hospitals
    healthcare-providers
    oncology
    cell-therapy
    cancer
    Gamida Cell logo

    Gamida Cell

    Acquired
    Cellular and Immune Therapies
    1998 B2B 51-200 Acquired $413.02M
    medical-technologies
    hospitals
    biological-therapy
    metabolic-disease
    stem-cells
    cancer
    therapeutics
    oncology
    hematology
    doctors
    healthcare-providers
    pharma-companies
    cell-therapy
    regenerative-medicine
    autoimmune-diseases
    treatments
    Anchiano Therapeutics logo

    Anchiano Therapeutics

    Presumed Inactive
    Targeted Cancer Therapies Based on H19 Gene
    2004 B2B 1-10 Acquired $37.7M
    cancer
    biotechnology
    biopharmaceutical
    cell-therapy
    biopsy
    targeted-therapy
    pharma-companies
    Applied Immune Technologies logo

    Applied Immune Technologies

    Presumed Inactive
    TCRL Antibodies for Therapeutic Applications
    2006 B2B 1-10 Acquired $4.4M
    viral-diseases
    cancer
    antibodies
    biotechnology
    biopharmaceutical
    therapeutics
    diagnostics
    autoimmune-diseases
    patients
    doctors
    Ayala Pharmaceuticals logo

    Ayala Pharmaceuticals

    Acquired
    Targeted Therapies for People with Rare Cancers
    2017 B2B 11-50 Acquired $102M
    rare-diseases
    cancer
    genomics
    cell-therapy
    drug-discovery
    oncology
    therapeutics
    pharmaceuticals
    life-sciences
    patients
    BioSight logo

    BioSight

    Presumed Inactive
    Therapeutics for Oncology and Hematological Disorders
    1999 B2B 1-10 Acquired $62.5M
    chemotherapy
    cancer
    drug-discovery
    biopharmaceutical
    targeted-therapy
    pharmaceuticals
    cancer-therapy
    oncology
    hematology

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    22 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $1.27B
      Raised
      54
      Events
    • Private Funding
      $430.75M
      Raised
      19
      Rounds
    • Public Offerings
      $390M
      Raised
      15
      Offerings
    • M&A
      $450M
      Raised
      20
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    CANNDOC Pharma logo
    Raised
    Undisclosed
    CANNDOC Pharma
    Acquired
    Pharma-grade Cannabis Products
    Founded:2008
    Business Model:B2B, B2B2C, B2C, B2G
    Employees:1-10
    Funding Stage:Acquired
    ImmPACT Bio logo
    Raised
    $137M
    ImmPACT Bio
    Acquired
    CAR-T Cell Therapies for Treating Cancer
    Founded:2017
    Business Model:B2B
    Employees:51-200
    Funding Stage:Acquired
    Gamida Cell logo
    Raised
    $413.02M
    Gamida Cell
    Acquired
    Cellular and Immune Therapies
    Founded:1998
    Business Model:B2B
    Employees:51-200
    Funding Stage:Acquired
    Anchiano Therapeutics logo
    Raised
    $37.7M
    Anchiano Therapeutics
    Presumed Inactive
    Targeted Cancer Therapies Based on H19 Gene
    Founded:2004
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    Applied Immune Technologies logo
    Raised
    $4.4M
    Applied Immune Technologies
    Presumed Inactive
    TCRL Antibodies for Therapeutic Applications
    Founded:2006
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    Ayala Pharmaceuticals logo
    Raised
    $102M
    Ayala Pharmaceuticals
    Acquired
    Targeted Therapies for People with Rare Cancers
    Founded:2017
    Business Model:B2B
    Employees:11-50
    Funding Stage:Acquired
    BioSight logo
    Raised
    $62.5M
    BioSight
    Presumed Inactive
    Therapeutics for Oncology and Hematological Disorders
    Founded:1999
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    Access Comprehensive Financial Analytics
    Create a free account to:
    • Explore detailed financial analytics.
    • Track company growth and size.
    • Connect with company team members.
    I already have access,
    I already have access,